Jafron Biomedical Co.,Ltd. (SHE:300529)
China · Delayed Price · Currency is CNY 17.95
+0.22 (1.24%)
Apr 1, 2026, 3:04 PM CST
Jafron Biomedical Market Cap
Jafron Biomedical has a market cap or net worth of 13.73 billion as of April 1, 2026. Its market cap has decreased by -31.65% in one year.
Market Cap
13.73B
Enterprise Value
12.67B
Revenue
2.04B
Ranking
n/a
PE Ratio
28.17
Stock Price
17.95
Market Cap Chart
Since August 2, 2016, Jafron Biomedical's market cap has increased from 6.41B to 13.73B, an increase of 114.30%. That is a compound annual growth rate of 8.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 13.73B | -9.86% |
| Dec 31, 2025 | 15.23B | -32.96% |
| Dec 31, 2024 | 22.72B | 27.96% |
| Dec 29, 2023 | 17.76B | -28.23% |
| Dec 30, 2022 | 24.74B | -42.00% |
| Dec 31, 2021 | 42.65B | -21.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 2, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Autobio Diagnostics | 19.11B |
| Double Medical Technology | 17.80B |
| Shandong Weigao Blood Purification Products | 15.37B |
| MeHow Innovative | 14.41B |
| Beijing Balance Medical Technology | 13.68B |
| Shanghai MicroPort Endovascular MedTech | 12.28B |
| Shandong Weigao Orthopaedic Device | 12.23B |
| Cofoe Medical Technology | 11.43B |